Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
D048868:Adaptor Proteins, Signal Transducing; D018354:Alphavirus Infections / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D019149:Bioreactors; D016466:CHO Cells / Q000473:pathology* / Q000821:virology*; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D018929:Cell Culture Techniques / Q000379:methods; D002470:Cell Survival; D006224:Cricetinae; D003412:Cricetulus; D016895:Culture Media, Serum-Free; D019610:Cytoprotection; D008322:Mammals; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D012845:Sindbis Virus; D019311:Staurosporine / Q000494:pharmacology*; D051020:bcl-X Protein
C412506:AVEN protein, human; D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; D002352:Carrier Proteins; D016895:Culture Media, Serum-Free; D008565:Membrane Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D011994:Recombinant Proteins; D051020:bcl-X Protein; D019311:Staurosporine